tradingkey.logo

Catheter Precision Inc

VTAK

0.167USD

-0.006-3.76%
Horarios del mercado ETCotizaciones retrasadas 15 min
1.54MCap. mercado
PérdidaP/E TTM

Catheter Precision Inc

0.167

-0.006-3.76%
Más Datos de Catheter Precision Inc Compañía
Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.
Información de la empresa
Símbolo de cotizaciónVTAK
Nombre de la empresaCatheter Precision Inc
Fecha de salida a bolsaSep 27, 2018
Director ejecutivoMr. David Jenkins
Número de empleados22
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 27
Dirección1670 Highway 160 West
CiudadFORT MILL
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal29708
Teléfono19736912000
Sitio Webhttps://www.ramed.com/
Símbolo de cotizaciónVTAK
Fecha de salida a bolsaSep 27, 2018
Director ejecutivoMr. David Jenkins
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
194.18K
--
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
40.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
194.18K
--
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
40.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
135.00K
94.41%
All other countries
8.00K
5.59%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 1 de ago
Actualizado: vie., 1 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Jenkins Family Charitable Institute
5.56%
Armistice Capital LLC
1.99%
Jenkins (David A)
1.54%
Warberg Asset Management LLC
1.43%
FatBoy Capital LP
0.56%
Other
88.91%
Accionistas
Accionistas
Proporción
Jenkins Family Charitable Institute
5.56%
Armistice Capital LLC
1.99%
Jenkins (David A)
1.54%
Warberg Asset Management LLC
1.43%
FatBoy Capital LP
0.56%
Other
88.91%
Tipos de accionistas
Accionistas
Proporción
Corporation
6.12%
Hedge Fund
3.87%
Individual Investor
1.87%
Investment Advisor/Hedge Fund
0.43%
Venture Capital
0.35%
Other
87.35%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
30
1.62M
12.88%
+271.92K
2025Q1
34
1.39M
13.16%
+226.78K
2024Q4
37
1.12M
13.97%
-215.80K
2024Q3
45
563.38K
38.63%
+376.14K
2024Q2
46
202.02K
23.51%
+5.34K
2024Q1
50
211.28K
24.77%
+47.42K
2023Q4
52
169.47K
25.10%
+5.69K
2023Q3
56
180.73K
31.24%
+30.19K
2023Q2
57
168.19K
29.83%
+996.00
2023Q1
61
185.84K
35.83%
+171.62K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Jenkins Family Charitable Institute
700.23K
5.56%
+200.00K
+39.98%
Jun 05, 2025
Armistice Capital LLC
250.97K
1.99%
+121.80K
+94.30%
Mar 31, 2025
Jenkins (David A)
194.18K
1.54%
--
--
Jun 05, 2025
Warberg Asset Management LLC
180.10K
1.43%
-130.06K
-41.93%
Mar 31, 2025
FatBoy Capital LP
70.97K
0.56%
--
--
Jan 29, 2025
Geode Capital Management, L.L.C.
54.21K
0.43%
+46.67K
+619.01%
Mar 31, 2025
XTX Markets LLC
44.70K
0.35%
+20.82K
+87.18%
Mar 31, 2025
Caruso (James Joseph)
34.76K
0.28%
+208.00
+0.60%
Jun 05, 2025
Citadel Advisors LLC
32.97K
0.26%
+32.97K
--
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Fecha
Tipo
Relación
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Jul 03, 2024
Merger
10<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Sep 21, 2022
Merger
50<1
Nov 16, 2020
Merger
25<1
Nov 16, 2020
Merger
25<1
Ver más
KeyAI